近日，日本知名药企小林制药因公司生产的红曲成分保健品出现健康问题引起关注。据悉，该公司生产的一款名为“红曲丸”的保健品被指与多名消费者死亡事件有关。目前，小林制药已经宣布暂停销售该产品，并正在配合相关部门进行调查。
Title: Controversy Surrounding Safety of Xiao Lin Pharmaceutical’s Health Supplement
Keywords: Xiao Lin Pharmaceutical, Health Supplement, Safety Controversy
News content: Recently, Xiao Lin Pharmaceutical, a well-known Japanese pharmaceutical company, has come under scrutiny due to health issues related to its red yeast rice ingredient health supplement. The company’s product, called “Red Yeast Rice Pills,” is reportedly linked to the deaths of several consumers. In response, Xiao Lin Pharmaceutical has suspended sales of the product and is cooperating with authorities in the investigation.
【来源】http://www.chinanews.com/life/2024/03-26/10187222.shtml
Views: 2